Bone Metastases
FDA approves two new biosimilars of denosumab
The FDA has approved two new biosimilars of denosumab to treat osteoporosis, increase bone mass, prevent skeletal-related events for people with multiple myeloma and other indications, Samsung Bioepis announced.
ASTRO issues updated guideline for symptomatic bone metastases
The American Society for Radiation Oncology has issued an updated clinical guideline that outlines best practices for addressing symptomatic bone metastases and improving quality of life for these patients.
Treatments that ‘revolutionized cancer therapy’ may increase risk for bone damage
To help individuals who undergo cancer treatment lead healthier lives, Stacyann Bailey, PhD, has one overarching professional mission — to prevent bones from breaking.
Exercise program improves quality of life for patients with metastatic breast cancer
SAN ANTONIO — Patients with metastatic breast cancer who take part in a supervised, structured exercise program during palliative treatment may experience improved quality of life, according to study results.
Radiation therapy for asymptomatic bone metastases prolongs survival, prevents pain
Palliative radiation therapy for high-risk asymptomatic bone metastases significantly prolonged OS while reducing skeletal-related events compared with standard therapy, phase 2 trial results showed.
Bone metastases in bladder cancer predict worse outcomes
CHICAGO — Patients with bone metastases due to urothelial carcinoma had worse outcomes than those without bone metastasis, regardless of treatment or PD-L1 expression, according to a poster presentation at ASCO Annual Meeting.